piperacillin has been researched along with Infection, Wound in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.14) | 18.7374 |
| 1990's | 4 (28.57) | 18.2507 |
| 2000's | 3 (21.43) | 29.6817 |
| 2010's | 4 (28.57) | 24.3611 |
| 2020's | 2 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmed, EF; Darwish, AMA; Gad, GFM; Rasmi, AH | 1 |
| AlAzmi, A; AlHashem, G; Jamal, W; Khodakhast, FB; Rotimi, VO; Sόki, J | 1 |
| Ben Khalifa, S; Daiki, M; Fekih Hassen, A | 1 |
| Martínez-Ramos, D; Pérez-Bru, S; Salvador-Sanchís, JL | 1 |
| Gholipourmalekabadi, M; Hashemi, A; Mozafari, M; Rostami, A; Sameni, M; Zamani, F | 1 |
| Adukauskiene, D; Dambrauskiene, A; Jeroch, J; Vitkauskiene, A | 1 |
| Cavallo, JD; Chomarat, M; Dubreuil, L; Joly-Guillou, ML; Kempf, M; Maugein, J; Muller-Serieys, C; Roussel-Delvallez, M | 1 |
| Boghossian, J; Caputo, W; Dana, A; Gray, S; Harkless, L; Pollak, R; Wu, D | 1 |
| Al-Ebous, AD; Al-Jahmi, M; Al-Zuriqat, AN; Hiasat, B; Sarayrah, M | 1 |
| Blatun, LA; Iakovlev, VP; Izotova, GN; Svetukhin, AM; Terekhova, RP | 1 |
| Heggers, JP; Herndon, DN; Villarreal, C; Walton, MA | 1 |
| Czymek, R; Düsel, W; Lenz, S | 1 |
| Broc, V; Deligne, P; Dominici, L; Dubos, S; Gondret, R; Viallard, M | 1 |
| Fox, CL; Modak, S | 1 |
1 review(s) available for piperacillin and Infection, Wound
| Article | Year |
|---|---|
[Prevention of infection in war wounds].
Topics: Antibiotic Prophylaxis; Blast Injuries; Drug Therapy, Combination; Half-Life; Humans; Penicillanic Acid; Piperacillin; Practice Guidelines as Topic; Tazobactam; Warfare; Wound Infection; Wounds, Gunshot | 1999 |
4 trial(s) available for piperacillin and Infection, Wound
| Article | Year |
|---|---|
An open-label, randomized study comparing efficacy and safety of intravenous piperacillin/tazobactam and ampicillin/sulbactam for infected diabetic foot ulcers.
Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Infections; Diabetic Foot; Female; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Sulbactam; Time Factors; Vancomycin; Wound Infection | 2005 |
Management of diabetic foot in a Jordanian hospital.
Topics: Amikacin; Amputation, Surgical; Anti-Bacterial Agents; Ceftazidime; Chemotherapy, Adjuvant; Debridement; Diabetic Foot; Drug Combinations; Drug Monitoring; Humans; Imipenem; Kidney Diseases; Length of Stay; Lincomycin; Metronidazole; Patient Selection; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; Severity of Illness Index; Treatment Outcome; Wound Healing; Wound Infection | 2005 |
[Clinico-laboratory study of piperacillin/tazobactam in the treatment of patients with would infection].
Topics: Adolescent; Adult; Aged; beta-Lactamase Inhibitors; Drug Therapy, Combination; Female; Humans; Laboratories; Male; Microbial Sensitivity Tests; Middle Aged; Necrosis; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Recurrence; Soft Tissue Infections; Wound Infection | 1997 |
Antimicrobial prophylaxis for major head and neck cancer surgery with piperacillin and ornidazole.
Topics: Adult; Aged; Drug Therapy, Combination; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Ornidazole; Piperacillin; Postoperative Complications; Premedication; Prospective Studies; Wound Infection | 1992 |
9 other study(ies) available for piperacillin and Infection, Wound
| Article | Year |
|---|---|
Virulence genes distributed among Staphylococcus aureus causing wound infections and their correlation to antibiotic resistance.
Topics: Anti-Bacterial Agents; Cross-Sectional Studies; Drug Resistance, Microbial; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Piperacillin; Staphylococcal Infections; Staphylococcus aureus; Virulence; Virulence Factors; Wound Infection | 2022 |
Prevalence and antimicrobial susceptibility of enterotoxigenic extra-intestinal Bacteroides fragilis among 13-year collection of isolates in Kuwait.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Toxins; Bacteroides fragilis; Bacteroides Infections; Cefoxitin; Clindamycin; Drug Resistance, Bacterial; Feces; Female; Humans; Imipenem; Kuwait; Male; Meropenem; Metronidazole; Microbial Sensitivity Tests; Piperacillin; Prevalence; Prospective Studies; Respiratory Tract Infections; Sepsis; Tigecycline; Wound Infection | 2020 |
Epidemiological and bacteriological profiles in children with burns.
Topics: Anti-Bacterial Agents; Burns; Child; Child, Preschool; Cohort Studies; Cross Infection; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Gentamicins; Humans; Male; Oxacillin; Piperacillin; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Wound Infection | 2014 |
Empyema necessitatis following chest trauma.
Topics: Abscess; Anti-Bacterial Agents; Debridement; Diabetes Mellitus, Type 2; Disease Susceptibility; Empyema, Pleural; Hematoma; Humans; Male; Middle Aged; Obesity, Morbid; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pleural Effusion; Smoking; Streptococcal Infections; Streptococcus agalactiae; Thoracic Injuries; Wound Infection; Wounds, Nonpenetrating | 2014 |
Silver- and fluoride-containing mesoporous bioactive glasses versus commonly used antibiotics: Activity against multidrug-resistant bacterial strains isolated from patients with burns.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Aztreonam; Burns; Carbenicillin; Cefepime; Ceftazidime; Ceftriaxone; Cell Survival; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Fluorides; Gentamicins; Glass; Humans; Imipenem; Meropenem; Mice; Microbial Sensitivity Tests; NIH 3T3 Cells; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Silver; Thienamycins; Tobramycin; Wound Infection | 2016 |
[Pseudomonas aeruginosa bacteremia: associations with a source of infection and antibiotic resistance].
Topics: Amikacin; Anti-Bacterial Agents; Bacteremia; Bacteriological Techniques; Ceftazidime; Ciprofloxacin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Gentamicins; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Retrospective Studies; Thienamycins; Wound Infection | 2009 |
Comparative in vitro activity of Meropenem, Imipenem and Piperacillin/tazobactam against 1071 clinical isolates using 2 different methods: a French multicentre study.
Topics: Anti-Bacterial Agents; Bacteremia; France; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Bacterial; Thienamycins; Wound Infection | 2010 |
The use of aztreonam as an alternate therapy for multi-resistant Pseudomonas aeruginosa.
Topics: Aminoglycosides; Aztreonam; Burns; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Monobactams; Penicillins; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Treatment Outcome; Wound Infection | 1997 |
Synergistic action of silver sulfadiazine and sodium piperacillin on resistant Pseudomonas aeruginosa in vitro and in experimental burn wound infections.
Topics: Administration, Topical; Animals; Burns; Culture Media; Drug Synergism; Female; Mice; Penicillin Resistance; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Rats, Inbred Strains; Silver Sulfadiazine; Sulfadiazine; Wound Infection | 1985 |